# Metronidazole

## SABS inj 500mg/100mL

| TAH Drug Code      | [ISAB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ISAB){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment for severe infections caused by anaerobic bacteria sensitive to Metronidazole and infections caused by Bacteroides fragilis resistant to Clindamycin, Chloramphenicol, and Penicillin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Adult: (data from Micromedex) Infection caused by anaerobic bacteria, anaerobic abscess, bacterial meningitis: Loading dose, 15 mg/kg IV over 1 hour; maintenance dose, 7.5 mg/kg IV infused over 1 hour q6h, starting 6 hours after loading dose; duration 7-10 days or longer as clinically indicated; MAX 4 g/day. Postoperative infection; Prophylaxis: 500 mg IV 1 hour prior-surgery; total treatment duration should not exceed 24 hours OR 15 mg/kg IV over 30-60 minutes, complete 1 hour before surgery; follow with 7.5 mg/kg IV over 30-60 minutes at 6 and 12 hours after initial dose; limit treatment-day of surgery and discontinue within 12 hours following completion of surgery. Postoperative infection; Prophylaxis - Procedure on female genital system: 500 mg IV single dose plus single dose of either gentamicin 1.5 mg/kg IV or a quinolone (ciprofloxacin, levofloxacin, moxifloxacin) 400 mg IV Clostridium difficile diarrhea, including Pseudomembranous Colitis: Fulminant disease, 500 mg IV q8h plus vancomycin 500 mg orally/NG tube QID; if complete ileus, consider adding vancomycin retention enema (500 mg in 100 mL normal saline) rectally q6h. Necrotizing fasciitis (Mixed infection): 500 mg IV q6h PLUS cefotaxime 2 g IV q6h; administer until further debridement is no longer necessary, the patient has clinically improved, and has been afebrile for 48-72 hours. Pediatric (Infants, Children, and Adolescents): (package insert: not established; below data from Lexidrug) IV 22.5-40 mg/kg/day in divided doses q6h to q8h; MAX 4 g/day. Surgical prophylaxis (Children and Adolescents): IV 15 mg/kg as a single dose 30-60 minutes prior to procedure; MAX 500 mg/dose. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | [Micromedex] Hypersensitivity to metronidazole or any other component of the product or to other nitroimidazole agents. Alcohol, or products containing propylene glycol, use during and for at least 3 days after metronidazole use. Concomitant use with or within the last 2 weeks of disulfiram. Cockayne syndrome. [Package insert] Patients with blood disorders (may experience leukopenia). Patients with brain or spinal cord disorders (may exhibit central nervous system symptoms). Women in the first three months of pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Common: Abdominal discomfort (4-7%), Abnormal taste in mouth (2-9%), Diarrhea (1-4%), Nausea (1.6-10%), Jarisch Herxheimer reaction, Dizziness (2-4%), Headache (Vaginal gel and topical, 2.2-5%; extended-release tablets, 18%), Candida infection of genital region, Vaginal discharge (12%), Vaginal irritation (9%), Vaginitis (15%) Serious: Prolonged QT interval, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Leukopenia, Hepatic failure, acute, Hepatotoxicity, Aseptic meningitis, Encephalopathy, Peripheral neuropathy, Seizure, Disorder of optic nerve, Ototoxicity, Hemolytic uremic syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/metronidazole-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

## Metrozole 250mg

| TAH Drug Code      | [OMETR](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMETR){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Vaginitis caused by Trichomonas. Amebiasis & metronidazole-susceptible anaerobic infection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | (仿單) Adults: Anaerobic infections: 7.5 mg/kg Q6H for 7 days (maximum 1 g/dose; 4 g/day).Helicobacter pylori: 500 mg orally Q8H in combination with bismuth and other antibiotics for 1-2 weeks. Amebiasis: 500-700 mg orally Q8H for 5-7 days. Trichomoniasis: 2 g orally as a single dose, 1 g Q12H for 1 day or 250 mg Q8H for 7 days. Dracunculiasis: 250 mg Q8H for 10 days. Children: Anaerobic infections:7.5 mg/kg Q6H or 10 mg/kg Q8H. Amebiasis: 11.6-16.7 mg/kg Q8H for 10 days. Trichomoniasis: 5 mg/kg Q8H for 7 days. Dracunculiasis: 8.3 mg/kg (max 250 mg/dose) Q8H for 10 days. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Blood dyscrasias. Active CNS disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | GI disturbances; peripheral neuropathy; drowsiness; leukopenia; rarely, skin reactions, darkening of urine, anaphylaxis, encephalopathy. Gastrointestinal: Abdominal discomfort (7%), Loss of appetite, Metallic taste, Nausea and vomiting (4%) Immunologic: Jarisch Herxheimer reaction Neurologic: Dizziness (1% to 4% ), Headache (tablets, 15% to 18%; vaginal gel, 5% ), Peripheral neuropathy Reproductive: Candida infection of genital region, Symptomatic cervicitis/vaginitis (10%), Vaginal discharge (12%) Other: Drug interaction with alcohol, Disulfiram-like reaction            |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | Hold Breast Feeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/metronidazole-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

